| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -318.4% | -1006.0% |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 29.5 | 111.3 |
| Pr/Book | n/a |
| Latest | F'cast | |
|---|---|---|
| Revenue | n/a | -73.5% |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Apr-21 | n/a | (16.81) | (2.28)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Apr-22 | n/a | (6.27) | (0.56)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Apr-23 | 5.27 | (14.30) | (1.50)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Apr-24 | n/a | (9.12) | (0.68)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Apr-25 | 4.71 | (15.30) | (1.26)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Apr-26 | 1.25 | (12.57) | (0.93)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Apr-27 | n/a | (17.77) | (1.41)p | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
| /C O R R E C T I O N -- KushoAI/ | 02-Apr-2026 | ShareCast |
| FDA clears Scancell's application for phase thre... | 26-Jan-2026 | ShareCast |
| Scancell reports further data from DNA cancer im... | 09-Dec-2025 | ShareCast |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 13.25p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 13.83 |
| 52 Week Low | 8.54 |
| Volume | 324,457 |
| Shares Issued | 1,037.78m |
| Market Cap | £137.51m |
| Value | ![]() |
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| Strong Buy | 1 |
| Buy | 2 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 3 |

| No dividends found |
| Time | Volume / Share Price |
| 16:09 | 5,073 @ 13.22p |
| 16:08 | 371 @ 13.48p |
| 15:59 | 8,000 @ 13.22p |
| 15:36 | 10,000 @ 13.22p |
| 15:05 | 1,670 @ 13.35p |
| CFO | Sath Nirmalananthan |
| CEO | Phil L'Huillier |
You are here: research